Showing results (1-10 of 25) with videos related to
Sort By:
Pageof 3
Journal of Pharmaceutical Sciences|January 1, 1978
Vasodilator activity of adenosine analogsA Gangjee, H P Hogenkamp, J M KitzenThe Journal of Pharmacology and Experimental Therapeutics|August 1, 1978
Pharmacology of 6,7-dihydroxy-2-dimethylaminotetralin (TL-99). I. Cardiovascular activity in the dog and catJ M Kitzen, J P Long, J G CannonEuropean Journal of Pharmacology|August 1, 1976
Alpha-adrenergic activity of N,N-dimethyldopamine (DMDA)J M Kitzen, M Ilhan, J G Cannon, et al.European Journal of Pharmacology|February 7, 1977
Aminotetralins as selective beta-adrenergic agonistsM Ilhan, J M Kitzen, J G Cannon, et al.Journal of Cardiovascular Pharmacology|December 1, 1991
Antithrombotic activity of the phosphodiesterase III inhibitor pelrinone in a canine model of coronary artery thrombosis: enhancement of efficacy with concurrent alpha 2-adrenergic antagonismJ M Kitzen, J D McCallum, C Harvey, et al.Life Sciences|January 1, 1991
Potentiation of phosphodiesterase inhibitor antithrombotic activity with alpha-2 adrenergic blockadeJ M Kitzen, J D McCallum, C T Pirozzi, et al.Hypertension (Dallas, Tex. : 1979)|August 1, 1993
Angiotensin subtype 1 blockade selectively potentiates adenosine subtype 2-mediated vasodilationG J Smits, J M Kitzen, M H Perrone, et al.Journal of Cardiovascular Pharmacology|July 1, 1990
Effects of combined thromboxane synthetase inhibition/thromboxane receptor antagonism in two models of sudden cardiac death in the canine: limited role for thromboxaneJ M Kitzen, L G Chi, A C Uprichard, et al.Journal of Cardiovascular Pharmacology|January 1, 1988
Effects of pimobendan (UD-CG 115 BS), a new positive inotropic agent, on ventricular tachycardia and ischemic ventricular fibrillation in a conscious canine model of recent myocardial infarctionJ J Lynch, J M Kitzen, P T Hoff, et al.Journal of Medicinal Chemistry|March 1, 1984
(+/-)-4-Aryl-4,5-dihydro-3H-1,3-benzodiazepines. 3. 2-Phenyl and 2-amino analogues as potential antihypertensive agentsL L Setescak, F W Dekow, J M Kitzen, et al.Pageof 3